Stay updated with breaking news from Dan Budwick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a Phase 3 clinical trial, the addition of sugemalimab to chemotherapy improved median overall survival by 8.5 month...
$532.2 Million in Total Cash at Quarter End; Strong Balance Sheet Expected to Support Operations into Second Half of 2024 Additional Data from Adintrevimab Phase 2/3 STAMP Treatment Trial to be...
-- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
(2022-05-05 | NDAQ:GRTS) Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update